| Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673) |
|---|
| 03/03/2005 | WO2005019831A2 Methods for reducing complexity of a sample using small epitope antibodies |
| 03/03/2005 | WO2005019243A1 Detecting molecules |
| 03/03/2005 | WO2005018803A1 Immobilization matrix for peptides and proteins |
| 03/03/2005 | WO2005018575A2 Estrogen receptor modulators and uses thereof |
| 03/03/2005 | WO2004096831A3 Method of producing three-dimensional structures using motor proteins |
| 03/03/2005 | US20050048029 Nucleotide sequence for diagnosis, prevention, therapy of cancer, inflammation, autoimmune disease and infections |
| 03/03/2005 | CA2536946A1 Estrogen receptor modulators and uses thereof |
| 03/03/2005 | CA2536062A1 Methods for reducing complexity of a sample using small epitope antibodies |
| 03/03/2005 | CA2535753A1 Neurogenin3 and production of pancreatic islet cells |
| 03/02/2005 | EP1509336A1 Synthesis of inorganic structures using templation and catalysis by self assembled repeat protein polymers |
| 03/02/2005 | EP1141391B1 Method for making a biochip and biochip |
| 02/24/2005 | WO2005016974A1 Sialic acid derivatives for protein derivatisation and conjugation |
| 02/24/2005 | WO2005016971A1 Organic material-immobiling structure and method for production of the same, and peptide and dna therefor |
| 02/24/2005 | WO2005016949A2 Sialic acid derivatives |
| 02/24/2005 | WO2005016283A2 Peptides for enhanced cell attachment and growth |
| 02/24/2005 | US20050042704 Entrapped binding protein as biosensors |
| 02/24/2005 | US20050042602 Monitoring immunologic, Hematologic and inflammatory diseases |
| 02/24/2005 | DE10334097A1 Preparation of layers on a semiconductor surface, for use as a biosensor, uses a medium containing an organic substance against the substrate for an electrical voltage to give organic deposits on the surface as an organic layer |
| 02/24/2005 | DE10334096A1 Preparation of layers on a semiconductor surface, for use as a biosensor, uses a medium containing an organic substance against the substrate for an electrical voltage to give organic deposits on the surface as an organic layer |
| 02/24/2005 | CA2524737A1 Antibodies that immunospecifically bind to trail receptors |
| 02/23/2005 | EP1507792A1 Device for the presentation of peptides or proteins, method for the preparation and use thereof |
| 02/23/2005 | CN1583793A Human alpha 1-thymic peptide composition and its preparation |
| 02/22/2005 | US6858581 Peptides which are modified with at least one hydrocarbyl group and which possess antimicrobial acitivity |
| 02/17/2005 | WO2005014792A2 Preservation of biomaterials with transported preservation agents |
| 02/17/2005 | WO2005013889A2 Truncated fragments of alpha-synuclein in lewy body disease |
| 02/17/2005 | US20050039220 Labeled coronavirus protein for use as diagnostic tool in detection of viral infection; viricides and vaccine development for treatment and prevention of respiratory system disorders |
| 02/17/2005 | US20050038228 Makes it possible to selectively adsorb an immunoglobulin and/or an immune complex present in a body fluid (for example, blood, plasma, etc.) efficiently without pretreating the body fluid |
| 02/17/2005 | US20050036980 cell adhesion promoting (CAP) peptide combinations that promote cell attachment or cell adhesion to culture surfaces that are otherwise cell adhesion resistant CAR); peptides when coupled to a CAR layer such as hyaluronic acid that has been created on a polymer surface, promote cell growth |
| 02/17/2005 | CA2844154A1 Polysaccharide-protein conjugate vaccines |
| 02/17/2005 | CA2526900A1 Truncated fragments of alpha-synuclein in lewy body disease |
| 02/16/2005 | CN1580082A Efficent polyethylene glycol activating process and activate use for protein modification |
| 02/10/2005 | WO2005012479A2 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 02/10/2005 | WO2005012362A1 Methods for producing an arrangement comprising a plurality of layers on the base of a semiconductor substrate, multi-layer arrangement, and biosensor |
| 02/10/2005 | WO2005011607A2 Treatment of cancers expressing p95 erbb2 |
| 02/10/2005 | WO2004083807A3 Methods of evaluating glycomolecules for enhanced activities |
| 02/10/2005 | WO2004058188A3 Vaccine compositions and methods |
| 02/10/2005 | US20050031635 Inducing specific B cell anergy to an immunogen comprising a conjugate of a nonimmunogenic valency platform molecule and an analog of the immunogen that (a) binds specifically to B cells to which the immunogen binds and (b) lacks the T cell epitope(s) of the immunogen |
| 02/10/2005 | CA2530172A1 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 02/09/2005 | EP1056860B1 High affinity humanized anti-tag-72 monoclonal antibodies |
| 02/08/2005 | US6852839 Fhm, a novel member of the TNF ligand supergene family |
| 02/08/2005 | CA2184183C Inhibin compositions and methods of use thereof |
| 02/03/2005 | WO2005010530A1 Gelatin based substrate for protein-biochips |
| 02/03/2005 | WO2005010151A2 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 02/03/2005 | WO2005009396A2 Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections |
| 02/03/2005 | WO2005009363A2 Treatment of pre-cancerous conditions and prevention of cancer using pcdgf-based therapies |
| 02/03/2005 | WO2005009217A2 Diagnosis of pre-cancerous conditions using pcdgf agents |
| 02/03/2005 | CA2530285A1 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 02/03/2005 | CA2517600A1 Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections |
| 02/02/2005 | EP1501925A2 Identification of a phage associated lytic enzyme to rapidly and specifically detect and kill bacillus anthracis |
| 02/02/2005 | EP1501542A1 Improved polysaccharide and glycoconjugate vaccines |
| 02/02/2005 | EP1372686B1 Methods and compositions for peptide synthesis |
| 02/01/2005 | US6849431 Non-B, non-C, non-G hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus |
| 01/27/2005 | WO2005007844A1 Method of screening for agents that modulate immunophilin/peptidylproline cis-trans isomerase (ppiase)-homer interaction |
| 01/27/2005 | WO2004060041A3 Kim-1 antagonists and use to modulate immune system |
| 01/27/2005 | US20050019828 Gelatin coated receiver as protein microarray substrate |
| 01/27/2005 | US20050019823 Using enhanced concentration of transmembrane polypeptide as diagnostic indicator of cell proliferative disorers; diagnosing cancer; antitumor agents |
| 01/27/2005 | US20050019751 Contacting human scavenger receptor class B type I with polypeptide and measuring ability of test compound to inhibit binding; used in treatment and prophylaxis |
| 01/26/2005 | CN1569892A Multi-branched polyethylene glycol and protein or polypeptide combined products and their preparation method |
| 01/25/2005 | US6846681 Functionalized silicon surfaces |
| 01/25/2005 | CA2089853C Polyethylene glycol-hirudine conjugates, process for their preparation, and their use in thrombosis therapy |
| 01/20/2005 | WO2005005614A2 Combined b-cell and t-cell epitopes on vlp for improved vaccines |
| 01/20/2005 | WO2005004798A2 Methods for treating lentivirus infections |
| 01/20/2005 | WO2004033488B1 Peptide mediated synthesis of metallic and magnetic materials |
| 01/20/2005 | US20050013826 Administering modified protein having disruptive element located in internal region; enhancing ubiquitin proteasome system degradation; effective, long term T cell response |
| 01/20/2005 | CA2528120A1 Methods for treating lentivirus infections |
| 01/19/2005 | EP1497469A2 Assay for evaluation of activity of compounds against hcv using a novel detection system in the hcv replicon |
| 01/19/2005 | EP1496926A1 Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins |
| 01/19/2005 | EP1458760A4 Entrapped binding proteins as biosensors |
| 01/19/2005 | CN1185260C Protein A immunoadsorption material for cleaning blood and method for synthesizing same |
| 01/18/2005 | US6844181 Method of inhibiting fungal growth |
| 01/13/2005 | WO2004043141A3 Novel inhibin-related multiple antigenic peptide compositions that enhance production performance in avians |
| 01/13/2005 | US20050010043 Recombinant flavivirus for use in generation of vaccines to prevent and treat hemorrhagic fever |
| 01/13/2005 | US20050009741 Copolymer made by depolymerizing chitosan and acylating such as with glutaryl and propionyl groups; mixture with peptides such as buserelin, deslorelin, histrelin; ionic conjugate with parathyroid hormone |
| 01/13/2005 | US20050009077 Composition of matter comprising library of first nucleic acid analyte copies |
| 01/13/2005 | US20050009014 Sequence specific reagents attached to a solid substrate and capable of specifically binding to predetermined subunit sequence (polynucleotide or polypeptide) |
| 01/12/2005 | EP1494706A2 Antimicrobial polymer conjugates |
| 01/12/2005 | EP0750513B1 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
| 01/12/2005 | CN1562963A Method for preparing 2 metho 4 chlorine artificial half antigen, artificial antigen, specific antibody and application |
| 01/12/2005 | CN1184233C Erytrocyte-stimulating factor coupling |
| 01/06/2005 | US20050003451 Immunoglobulin for use in diagnosis, prevention and treatment of infection, autoimmune, inflammatory and cell proliferative diseases; immunotherapy |
| 01/06/2005 | US20050003431 Monovalent, multivalent, and multimeric MHC binding domain fusion proteins and conjugates, and uses therefor |
| 01/06/2005 | US20050003345 Synthetic antigens for the detection of antibodies to hepatitis C virus |
| 01/06/2005 | US20050002875 Peptide which binds to integrin |
| 01/05/2005 | CN1183112C PEG-inerferon conjugate |
| 01/04/2005 | US6838237 Antigenically reactive regions of the hepatitis a virus polyprotein |
| 12/30/2004 | US20040266688 Methods for modulating endometrium |
| 12/30/2004 | US20040265974 Human chemokine polypeptides |
| 12/30/2004 | US20040265913 Tumor necrosis factors (TNF); humanized/chimeric monoclonal antibodies; fab fragments; hybridomas, host cells, Chinese Hamster Ovary cells |
| 12/30/2004 | US20040265392 Nanoparticles comprising biologically active tnf which is immobilized on the same |
| 12/29/2004 | WO2004112727A2 Aav virions with decreased immunoreactivity and uses therefor |
| 12/29/2004 | WO2004112572A2 Monitoring immunologic, hematologic and inflammatory diseases |
| 12/29/2004 | WO2004096124A3 Compositions and methods for the diagnosis and treatment of tumor |
| 12/29/2004 | CN1558774A Angiotensin peptide-carrier conjugates and uses thereof |
| 12/29/2004 | CA2529045A1 Monitoring immunologic, hematologic and inflammatory diseases |
| 12/23/2004 | WO2004111259A2 Hydrolytic substrates for an analyte-dependent enzyme activation system |
| 12/23/2004 | WO2004110390A2 Anti-cd74 immunoconjugates and methods |
| 12/23/2004 | WO2004110370A2 Etiologic agnet for sow infertility syndrome |
| 12/23/2004 | CA2529496A1 Anti-cd74 immunoconjugates and methods |
| 12/22/2004 | EP1487866A1 Novel polypeptide scaffolds and use thereof |
| 12/22/2004 | EP1487862A2 Polymer supported reagents for natural products purification |